7,8-Dihydroxyflavone
(Synonyms: 7,8-二羟基黄酮) 目录号 : GC16853
7,8-Dihydroxyflavone(7,8-二羟基黄酮)是一种高亲和力酪氨酸激酶受体B(TrkB)激动剂,IC50值为0.26μM 。
Cas No.:38183-03-8
Sample solution is provided at 25 µL, 10mM.
7,8-Dihydroxyflavone is a naturally-occurring plant-based flavone and high-affinity tyrosine kinase receptor B (TrkB) agonist with an IC50 value of 0.26μM[1,2]. TrkB is a protein tyrosine kinase receptor, and its primary ligand Brain-derived neurotrophic factor (BDNF) is expressed in neurons and skeletal muscles during the differentiation period and in the adult, promoting neuronal survival and differentiation, synaptic plasticity, and development of myoblasts and muscle fibers, as well as regulating energy metabolism and regeneration of the muscles[3]. 7,8-Dihydroxyflavone can be used as an adjunctive treatment in schizophrenia[4].
In vitro, treatment of MC3T3-E1 cells with 7,8-Dihydroxyflavone (0.5-5μM) for 24-48h resulted in a significant increase in cyclin mRNA levels in the cells, promoting cell proliferation and differentiation[5]. After 48h treatment with 7,8-Dihydroxyflavone (10-300μM) in cardiac fibroblasts (CFs) stimulated by TGF-β1, 7,8-Dihydroxyflavone significantly reduced the viability of CFs and inhibited TGF-β1-induced CFs activity in a dose-dependent manner[6].
In vivo, administration of 7,8-Dihydroxyflavone (5mg/kg/day) via intraperitoneal injection for 28days in mice fed a high-energy diet (cafeteria diet, CAF). 7,8-Dihydroxyflavone reduced body weight and downregulated the percentage indices of epididymal adipose tissue and adipocytes. The treatment also significantly decreased triglyceride, cholesterol, amylase, alanine aminotransferase (ALT), and glucose levels[7]. In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease mice, 5-day intraperitoneal treatment with 7,8-Dihydroxyflavone (5mg/kg/day) effectively blocked the loss of tyrosine hydroxylase (TH)-positive neurons, exerted beneficial effects on motor function and neuropathology through autophagy mechanisms[8].
References:
[1] Paul R, Nath J, Paul S, et al. Suggesting 7,8-dihydroxyflavone as a promising nutraceutical against CNS disorders[J]. Neurochem Int, 2021, 148: 105068.
[2] Tasdemir D, Kaiser M, Brun R, et al. Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies[J]. Antimicrob Agents Chemother, 2006, 50(4): 1352-64.
[3] Deng C, Chen H. Brain-derived neurotrophic factor/tropomyosin receptor kinase B signaling in spinal muscular atrophy and amyotrophic lateral sclerosis[J]. Neurobiol Dis, 2024, 190: 106377.
[4] Du X, Hill R A. 7,8-Dihydroxyflavone as a pro-neurotrophic treatment for neurodevelopmental disorders[J]. Neurochem Int, 2015, 89: 170-80.
[5] Xue F, Zhao Z, Gu Y, et al. 7,8-Dihydroxyflavone modulates bone formation and resorption and ameliorates ovariectomy-induced osteoporosis[J]. Elife, 2021, 10.
[6] Hang P Z, Liu J, Wang J P, et al. 7,8-Dihydroxyflavone alleviates cardiac fibrosis by restoring circadian signals via downregulating Bmal1/Akt pathway[J]. Eur J Pharmacol, 2023, 938: 175420.
[7] Sahin E, Saglam N, Erdem S, et al. 7,8-Dihydroxyflavone alleviates Endoplasmic Reticulum Stress in cafeteria diet-induced metabolic syndrome[J]. Life Sci, 2022, 306: 120781.
[8] Zuo L, Dai C, Yi L, et al. 7,8-dihydroxyflavone ameliorates motor deficits via regulating autophagy in MPTP-induced mouse model of Parkinson's disease[J]. Cell Death Discov, 2021, 7(1): 254.
7,8-Dihydroxyflavone(7,8-二羟基黄酮)是一种高亲和力酪氨酸激酶受体B(TrkB)激动剂,IC50值为0.26μM [1,2]。TrkB是一种蛋白酪氨酸激酶受体,和其主要配体脑源性神经营养因子(BDNF)在分化期和成人的神经元和骨骼肌中表达,促进神经元的存活和分化、突触可塑性、成肌细胞和肌纤维的发育,以及调节肌肉的能量代谢和再生[3]。7,8-二羟基黄酮可作为精神分裂症的辅助治疗药物[4]。
在体外,7,8-二羟基黄酮(0.5-5μM)处理MC3T3-E1细胞24-48h,引起细胞中细胞周期蛋白mRNA水平的显著增加,促进了细胞的增殖和分化[5]。在TGF-β1 刺激下的心肌成纤维细胞(CFs)用7,8-二羟基黄酮(10-300μM)处理48h后,7,8-二羟基黄酮显著降低了CFs的存活力,同时以剂量依赖的方式抑制TGF-β1诱导的CFs的活性[6]。
在体内,7,8-二羟基黄酮(5mg/kg/day)通过腹腔注射治疗高能量饮食(自助餐饮食 (CAF))小鼠28天,降低了小鼠体重,同时下调了附睾脂肪组织和脂肪细胞指数百分比。7,8-二羟基黄酮治疗后甘油三酯、胆固醇、淀粉酶、丙氨酸氨基转移酶(ALT)和葡萄糖值显著降低[7]。7,8-二羟基黄酮(5mg/kg/day)通过腹腔注射治疗1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)诱导的帕金森病小鼠5天,显著阻断酪氨酸羟化酶(TH)阳性神经元的丢失,通过自噬对运动功能和神经病理学发挥有益作用[8]。
Cell experiment [1]: | |
Cell lines | Cardiac fibroblasts (CFs) |
Preparation Method | The cytotoxicity of 7,8-Dihydroxyflavone was evaluated by treating CFs with different concentrations of 7,8-Dihydroxyflavone (10, 30, 100, and 300μM) for 48h. The CFs were incubated with TGF-β1 (20ng/mL) for 48h with or without 7,8-Dihydroxyflavone. CFs were seeded on a 96-well plate and treated as designated, followed by the addition of CCK-8 reagent and incubated at 37◦C for 2h. Optical density was detected using a microplate reader at 450nm. |
Reaction Conditions | 10, 30, 100, and 300μM; 48h |
Applications | 7,8-Dihydroxyflavone significantly decreased the viability of CF and inhibited the viability of TGF-β1-induced CFs in a dose-dependent manner. |
Animal experiment [2]: | |
Animal models | C57BL/6 male mice |
Preparation Method | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) groups were administrated with MPTP (30mg/kg, i.p.) once a day for 5days. 7,8-Dihydroxyflavone (5mg/kg, i.p.) and chloroquine (50mg/kg, i.p.) were injected once a day during the whole process of experiments. The control groups received the same volume of sterile saline with or without 10% ethanol. |
Dosage form | 5mg/kg/day for 5days; Intraperitoneal injection |
Applications | 7,8-Dihydroxyflavone alleviates motor deficits and reduces the loss of dopaminergic neurons in MPTP-induced mouse model of Parkinson's disease. |
References: |
Cas No. | 38183-03-8 | SDF | |
别名 | 7,8-二羟基黄酮 | ||
化学名 | 7,8-dihydroxy-2-phenyl-4H-chromen-4-one | ||
Canonical SMILES | OC1=C(C2=CC=C1O)OC(C3=CC=CC=C3)=CC2=O | ||
分子式 | C15H10O4 | 分子量 | 254.24 |
溶解度 | ≥ 12.75mg/mL in DMSO | 储存条件 | Store at 4°C, stored under nitrogen |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
1 mM | 3.9333 mL | 19.6665 mL | 39.3329 mL |
5 mM | 0.7867 mL | 3.9333 mL | 7.8666 mL |
10 mM | 0.3933 mL | 1.9666 mL | 3.9333 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet